183 related articles for article (PubMed ID: 14675867)
1. Enumeration of latently infected CD4+ T cells from HIV-1-infected patients using an HIV-1 antigen ELISPOT assay.
Fondere JM; Planas JF; Huguet MF; Baillat V; Bolos F; Reynes J; Vendrell JP
J Clin Virol; 2004 Jan; 29(1):33-8. PubMed ID: 14675867
[TBL] [Abstract][Full Text] [Related]
2. Human immunodeficiency virus type 1 (HIV-1) antigen secretion by latently infected resting CD4+ T lymphocytes from HIV-1-infected individuals.
Fondere JM; Petitjean G; Huguet MF; Salhi SL; Baillat V; Macura-Biegun A; Becquart P; Reynes J; Vendrell JP
J Virol; 2004 Oct; 78(19):10536-42. PubMed ID: 15367620
[TBL] [Abstract][Full Text] [Related]
3. Enhanced culture assay for detection and quantitation of latently infected, resting CD4+ T-cells carrying replication-competent virus in HIV-1-infected individuals.
Siliciano JD; Siliciano RF
Methods Mol Biol; 2005; 304():3-15. PubMed ID: 16061962
[TBL] [Abstract][Full Text] [Related]
4. Early establishment of a pool of latently infected, resting CD4(+) T cells during primary HIV-1 infection.
Chun TW; Engel D; Berrey MM; Shea T; Corey L; Fauci AS
Proc Natl Acad Sci U S A; 1998 Jul; 95(15):8869-73. PubMed ID: 9671771
[TBL] [Abstract][Full Text] [Related]
5. The Pathway To Establishing HIV Latency Is Critical to How Latency Is Maintained and Reversed.
Rezaei SD; Lu HK; Chang JJ; Rhodes A; Lewin SR; Cameron PU
J Virol; 2018 Jul; 92(13):. PubMed ID: 29643247
[TBL] [Abstract][Full Text] [Related]
6. A stable latent reservoir for HIV-1 in resting CD4(+) T lymphocytes in infected children.
Persaud D; Pierson T; Ruff C; Finzi D; Chadwick KR; Margolick JB; Ruff A; Hutton N; Ray S; Siliciano RF
J Clin Invest; 2000 Apr; 105(7):995-1003. PubMed ID: 10749578
[TBL] [Abstract][Full Text] [Related]
7. In patients on prolonged HAART, a significant pool of HIV infected CD4 T cells are HIV-specific.
Demoustier A; Gubler B; Lambotte O; de Goër MG; Wallon C; Goujard C; Delfraissy JF; Taoufik Y
AIDS; 2002 Sep; 16(13):1749-54. PubMed ID: 12218385
[TBL] [Abstract][Full Text] [Related]
8. Detection and enumeration of HIV-1-producing cells by ELISPOT (enzyme-linked immunospot) assay.
Corne P; Huguet MF; Briant L; Segondy M; Reynes J; Vendrell JP
J Acquir Immune Defic Syndr Hum Retrovirol; 1999 Apr; 20(5):442-7. PubMed ID: 10225225
[TBL] [Abstract][Full Text] [Related]
9. In Vitro Reactivation of Replication-Competent and Infectious HIV-1 by Histone Deacetylase Inhibitors.
Banga R; Procopio FA; Cavassini M; Perreau M
J Virol; 2016 Feb; 90(4):1858-71. PubMed ID: 26656693
[TBL] [Abstract][Full Text] [Related]
10. CD4+ T cells spontaneously producing human immunodeficiency virus type I in breast milk from women with or without antiretroviral drugs.
Valea D; Tuaillon E; Al Tabaa Y; Rouet F; Rubbo PA; Meda N; Foulongne V; Bollore K; Nagot N; Van de Perre P; Vendrell JP
Retrovirology; 2011 May; 8():34. PubMed ID: 21569457
[TBL] [Abstract][Full Text] [Related]
11. A flexible model of HIV-1 latency permitting evaluation of many primary CD4 T-cell reservoirs.
Lassen KG; Hebbeler AM; Bhattacharyya D; Lobritz MA; Greene WC
PLoS One; 2012; 7(1):e30176. PubMed ID: 22291913
[TBL] [Abstract][Full Text] [Related]
12. Isolation and characterization of HIV-1-infected resting CD4+ T lymphocytes in breast milk.
Petitjean G; Becquart P; Tuaillon E; Al Tabaa Y; Valea D; Huguet MF; Meda N; Van de Perre P; Vendrell JP
J Clin Virol; 2007 May; 39(1):1-8. PubMed ID: 17387039
[TBL] [Abstract][Full Text] [Related]
13. Suppression of HIV replication in the resting CD4+ T cell reservoir by autologous CD8+ T cells: implications for the development of therapeutic strategies.
Chun TW; Justement JS; Moir S; Hallahan CW; Ehler LA; Liu S; McLaughlin M; Dybul M; Mican JM; Fauci AS
Proc Natl Acad Sci U S A; 2001 Jan; 98(1):253-8. PubMed ID: 11136258
[TBL] [Abstract][Full Text] [Related]
14. Biphasic decay of latently infected CD4+ T cells in acute human immunodeficiency virus type 1 infection.
Blankson JN; Finzi D; Pierson TC; Sabundayo BP; Chadwick K; Margolick JB; Quinn TC; Siliciano RF
J Infect Dis; 2000 Dec; 182(6):1636-42. PubMed ID: 11069234
[TBL] [Abstract][Full Text] [Related]
15. Reservoirs for HIV-1: mechanisms for viral persistence in the presence of antiviral immune responses and antiretroviral therapy.
Pierson T; McArthur J; Siliciano RF
Annu Rev Immunol; 2000; 18():665-708. PubMed ID: 10837072
[TBL] [Abstract][Full Text] [Related]
16. Analysis of human immunodeficiency virus type 1 gene expression in latently infected resting CD4+ T lymphocytes in vivo.
Hermankova M; Siliciano JD; Zhou Y; Monie D; Chadwick K; Margolick JB; Quinn TC; Siliciano RF
J Virol; 2003 Jul; 77(13):7383-92. PubMed ID: 12805437
[TBL] [Abstract][Full Text] [Related]
17. CD161
Li X; Liu Z; Li Q; Hu R; Zhao L; Yang Y; Zhao J; Huang Z; Gao H; Li L; Cai W; Deng K
mBio; 2019 Oct; 10(5):. PubMed ID: 31594817
[TBL] [Abstract][Full Text] [Related]
18. Assessment of immune function by lymphoproliferation underestimates lymphocyte functional capacity in HIV patients treated with highly active antiretroviral therapy.
Keane NM; Price P; Stone SF; John M; Murray RJ; French MA
AIDS Res Hum Retroviruses; 2000 Dec; 16(18):1991-6. PubMed ID: 11153082
[TBL] [Abstract][Full Text] [Related]
19. Chimeric Antigen Receptor T Cells Guided by the Single-Chain Fv of a Broadly Neutralizing Antibody Specifically and Effectively Eradicate Virus Reactivated from Latency in CD4+ T Lymphocytes Isolated from HIV-1-Infected Individuals Receiving Suppressive Combined Antiretroviral Therapy.
Liu B; Zou F; Lu L; Chen C; He D; Zhang X; Tang X; Liu C; Li L; Zhang H
J Virol; 2016 Nov; 90(21):9712-9724. PubMed ID: 27535056
[TBL] [Abstract][Full Text] [Related]
20. An anti-CD45RO immunotoxin kills latently infected human immunodeficiency virus (HIV) CD4 T cells in the blood of HIV-positive persons.
Saavedra-Lozano J; McCoig C; Xu J; Cao Y; Keiser P; Ghetie V; Siliciano RF; Siliciano JD; Picker LJ; Ramilo O; Vitetta ES
J Infect Dis; 2002 Feb; 185(3):306-14. PubMed ID: 11807712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
